| scholarly article | Q13442814 |
| P50 | author | Anita Zaidi | Q78651219 |
| Samba Sow | Q87002144 | ||
| Myron M. Levine | Q29564379 | ||
| Pedro L. Alonso | Q30315189 | ||
| Eric M Mintz | Q42947993 | ||
| Robert F Breiman | Q60502430 | ||
| James P Nataro | Q61771354 | ||
| Boubou Tamboura | Q61771420 | ||
| John Benjamin Ochieng | Q61771516 | ||
| Shahida Qureshi | Q62070915 | ||
| Inacio Mandomando | Q63214783 | ||
| Karen L Kotloff | Q63214788 | ||
| Richard Adebayo Adegbola | Q75114791 | ||
| P2093 | author name string | Mohammed Jahangir Hossain | |
| Thandavarayan Ramamurthy | |||
| Anowar Hossain | |||
| Dani Cohen | |||
| Martin Antonio | |||
| Sandra Panchalingam | |||
| Sharon M Tennant | |||
| Tamer H Farag | |||
| Abu Syed Golam Faruque | |||
| Sofie Livio | |||
| William C Blackwelder | |||
| Ciara E O'Reilly | |||
| Debasish Saha | |||
| Nancy A Strockbine | |||
| Dipika Sur | |||
| Dilruba Nasrin | |||
| Eileen M Barry | |||
| Joseph O Oundo | |||
| Kousick Biswas | |||
| Lynette Y Berkeley | |||
| Mark E Marohn | |||
| Sunil Sen | |||
| Yukun Wu | |||
| P2860 | cites work | Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media | Q81445405 |
| A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology | Q28767862 | ||
| Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries | Q30416070 | ||
| Housefly population density correlates with shigellosis among children in Mirzapur, Bangladesh: a time series analysis | Q30418588 | ||
| Some epidemiologic, clinical, microbiologic, and organizational assumptions that influenced the design and performance of the Global Enteric Multicenter Study (GEMS). | Q30423340 | ||
| The Global Enteric Multicenter Study (GEMS): impetus, rationale, and genesis | Q30423344 | ||
| Diagnostic microbiologic methods in the GEMS-1 case/control study | Q30423347 | ||
| A household survey of dysentery in Burundi: implications for the current pandemic in sub-Saharan Africa | Q30427196 | ||
| Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo | Q33617990 | ||
| Evolutionary genetics of a new pathogenic Escherichia species: Escherichia albertii and related Shigella boydii strains | Q33700197 | ||
| Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602 | Q33876803 | ||
| Strategy for cross-protection among Shigella flexneri serotypes | Q34000330 | ||
| Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro | Q34224319 | ||
| Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study | Q34345075 | ||
| Gastroenteritis in US Marines during Operation Iraqi Freedom | Q34555095 | ||
| Broadly protective Shigella vaccine based on type III secretion apparatus proteins | Q35805439 | ||
| The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study | Q36412034 | ||
| Enteric infections and the vaccines to counter them: future directions | Q36444089 | ||
| Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains | Q36720620 | ||
| Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road | Q36844719 | ||
| Progress and pitfalls in Shigella vaccine research | Q37105553 | ||
| Comparison of media for direct isolation and transport of Shigellae from Fecal specimens | Q37156160 | ||
| Diarrheal disease during Operation Desert Shield | Q39090383 | ||
| Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. | Q39146446 | ||
| Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile | Q39252440 | ||
| Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis | Q40211202 | ||
| Distribution of Shigella enterotoxin genes and secreted autotransporter toxin gene among diverse species and serotypes of shigella isolated from Andaman Islands, India | Q40277209 | ||
| Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain | Q41480678 | ||
| Stockpiling oral cholera vaccine | Q42426420 | ||
| Genetic organization of the she pathogenicity island in Shigella flexneri 2a. | Q42641418 | ||
| Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines | Q42966608 | ||
| Studies on vaccination against bacillary dysentery. 3. Effective oral immunization against Shigella flexneri 2a in a field trial | Q42982958 | ||
| Structural elucidation of the O-antigen of the Shigella flexneri provisional serotype 88-893: structural and serological similarities with S. flexneri provisional serotype Y394 (1c). | Q43859842 | ||
| An Outbreak of Dysentery Caused by Shigella dysenteriae Type 1 on a Coral Island in the Bay of Bengal | Q43877855 | ||
| Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection | Q44713046 | ||
| Epidemic Shiga bacillus dysentery in Central Africa | Q46490035 | ||
| Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. | Q50464343 | ||
| A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. | Q54158784 | ||
| Live oral Shigella vaccine: vaccination schedule and the effect of booster dose. | Q54362925 | ||
| Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. | Q54572055 | ||
| Prevalence of Shigella Enterotoxin 1 among Shigella Clinical Isolates of Diverse Serotypes | Q54601009 | ||
| Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children. | Q64948328 | ||
| Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei | Q67941446 | ||
| Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population | Q68134308 | ||
| Immunity in Shigellosis. II. Protection Induced by Oral Live Vaccine or Primary Infection | Q69156182 | ||
| Epidemic Shiga Bacillus Dysentery in Central America. II. Epidemiologic Studies in 1969 | Q69913265 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vaccine | Q134808 |
| multicenter clinical trial | Q6934595 | ||
| P304 | page(s) | 933-941 | |
| P577 | publication date | 2014-06-23 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Shigella isolates from the global enteric multicenter study inform vaccine development | |
| P478 | volume | 59 |
| Q49210830 | A Phase 2a Randomized Study to Evaluate the Safety and Immunogenicity of the 1790GAHB Generalized Modules for Membrane Antigen Vaccine against Shigella sonnei Administered Intramuscularly to Adults from a Shigellosis-Endemic Country |
| Q91827516 | A phase I trial of WRSS1, a Shigella sonnei live oral vaccine in Bangladeshi adults and children |
| Q92822336 | An Oral Inoculation Infant Rabbit Model for Shigella Infection |
| Q40126474 | An attenuated Shigella mutant lacking the RNA-binding protein Hfq provides cross-protection against Shigella strains of broad serotype. |
| Q30252849 | Analysis of Shigella flexneri Resistance, Biofilm Formation, and Transcriptional Profile in Response to Bile Salts. |
| Q52337397 | Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex. |
| Q64114469 | Booster Vaccination With GVGH 1790GAHB GMMA Vaccine Compared to Single Vaccination in Unvaccinated Healthy European Adults: Results From a Phase 1 Clinical Trial |
| Q93192095 | Burden of laboratory-confirmed shigellosis infections in Guatemala 2007-2012: results from a population-based surveillance system |
| Q26749369 | Cellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell Processes |
| Q92801042 | Characterization and immunogenicity of a Shigella flexneri 2a O-antigen bioconjugate vaccine candidate |
| Q38776163 | Characterization of a multicomponent live, attenuated Shigella flexneri vaccine |
| Q92487093 | Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human |
| Q35896237 | Combination vaccines against diarrheal diseases |
| Q91605594 | Complete genome sequence and annotation of the laboratory reference strain Shigella flexneri serotype 5a M90T and genome-wide transcriptional start site determination |
| Q91801457 | Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies |
| Q47795634 | Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy. |
| Q40486636 | Deletion of toxin-antitoxin systems in the evolution of Shigella sonnei as a host-adapted pathogen |
| Q33552828 | Design and rationale of a matched cohort study to assess the effectiveness of a combined household-level piped water and sanitation intervention in rural Odisha, India |
| Q40552716 | Development of recombinant vaccine candidate molecule against Shigella infection |
| Q55333715 | Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput Shigella Serum Bactericidal Assay. |
| Q52610160 | Dominant serotype distribution and antimicrobial resistance profile of Shigella spp. in Xinjiang, China. |
| Q35662104 | Draft Genome Sequence of 24570, the Type Strain of Shigella flexneri |
| Q28646046 | Draft genomes of Shigella strains used by the STOPENTERICS consortium |
| Q40622945 | Efficient Iterative Synthesis of O-Acetylated Tri- to Pentadecasaccharides Related to the Lipopolysaccharide of Shigella flexneri Type 3 a through Di- and Trisaccharide Glycosyl Donors |
| Q38379063 | Environmental transmission of diarrheal pathogens in low and middle income countries |
| Q41624662 | Epidemic characterization and molecular genotyping of Shigella flexneri isolated from calves with diarrhea in Northwest China |
| Q46180723 | Escherichia coli pathotypes and Shigella sero-groups in diarrheic children in Nairobi city, Kenya |
| Q64055283 | Evaluating Shigella flexneri Pathogenesis in the Human Enteroid Model |
| Q57068847 | Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella |
| Q36764372 | Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects |
| Q93090016 | Extensive inter-strain diversity among clinical isolates of Shigella flexneri with reference to its serotype, virulence traits and plasmid incompatibility types, a study from south India over a 6-year period |
| Q40981696 | Failure of Syndrome-Based Diarrhea Management Guidelines to Detect Shigella Infections in Kenyan Children. |
| Q35147903 | Gastrointestinal infections and diarrheal disease in Ghanaian infants and children: an outpatient case-control study |
| Q30277011 | Genome diversity of Shigella boydii |
| Q89635013 | Genome-wide association studies of Shigella spp. and Enteroinvasive Escherichia coli isolates demonstrate an absence of genetic markers for prediction of disease severity |
| Q55189235 | Genomic epidemiology of Shigella in the United Kingdom shows transmission of pathogen sublineages and determinants of antimicrobial resistance. |
| Q48224744 | Health worker knowledge of Integrated Disease Surveillance and Response standard case definitions: a cross-sectional survey at rural health facilities in Kenya |
| Q91166657 | Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection |
| Q92261979 | How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella? |
| Q36268162 | Identification and antimicrobial resistance patterns of bacterial enteropathogens from children aged 0-59 months at the University Teaching Hospital, Lusaka, Zambia: a prospective cross sectional study |
| Q47146418 | Identification and management of Shigella infection in children with diarrhoea: a systematic review and meta-analysis |
| Q99616552 | Immune Response Characterization after Controlled Infection with Lyophilized Shigella sonnei 53G |
| Q38648043 | In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity. |
| Q92237003 | In vitro and in vivo activity of ciprofloxacin/fosfomycin combination therapy against ciprofloxacin-resistant Shigella flexneri isolates |
| Q35621105 | Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study |
| Q34138990 | Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants |
| Q30368857 | Molecular characterization of Shigella spp. from patients in Gabon 2011-2013. |
| Q37163698 | Monoclonal Antibodies to Shigella Lipopolysaccharide Are Useful for Vaccine Production. |
| Q57927103 | Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016 |
| Q37747766 | Multiple etiologies of infectious diarrhea and concurrent infections in a pediatric outpatient-based screening study in Odisha, India |
| Q64084468 | Mutational convergence acts as a major player in adaptive parallel evolution of Shigella spp |
| Q41711298 | Newest data on fluoroquinolone resistance mechanism of Shigella flexneri isolates in Jiangsu Province of China |
| Q26779009 | O-antigen modifications providing antigenic diversity of Shigella flexneri and underlying genetic mechanisms |
| Q38605714 | Outer membrane proteins analysis of Shigella sonnei and evaluation of their antigenicity in Shigella infected individuals. |
| Q100512321 | Pre-existing Helicobacter pylori serum IgG enhances the vibriocidal antibody response to CVD 103-HgR live oral cholera vaccine in Malian adults |
| Q91583738 | Prevalence of Shigella boydii in Bangladesh: Isolation and Characterization of a Rare Phage MK-13 That Can Robustly Identify Shigellosis Caused by Shigella boydii Type 1 |
| Q35924773 | Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB |
| Q41609325 | Programmed chemo-enzymatic synthesis of the oligosaccharide component of a carbohydrate-based antibacterial vaccine candidate |
| Q41008205 | Purification and characterization of a Shigella conjugate vaccine, produced by glycoengineering Escherichia coli |
| Q36765670 | Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations |
| Q38376613 | Recent Outbreaks of Shigellosis in California Caused by Two Distinct Populations of Shigella sonnei with either Increased Virulence or Fluoroquinolone Resistance. |
| Q57945192 | Recent insights into Shigella |
| Q38665950 | Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe. |
| Q37477196 | Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study. |
| Q39056494 | Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I study |
| Q102056730 | Safety and immunogenicity of a synthetic carbohydrate conjugate vaccine against Shigella flexneri 2a in healthy adult volunteers: a phase 1, dose-escalating, single-blind, randomised, placebo-controlled study |
| Q59202030 | Serotype Distribution and Antimicrobial Resistance of Species in Bangui, Central African Republic, from 2002 to 2013 |
| Q91881906 | Serum IgG antibodies to Shigella lipopolysaccharide antigens - a correlate of protection against shigellosis |
| Q36935306 | Shigella Antimicrobial Drug Resistance Mechanisms, 2004-2014. |
| Q35946462 | Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice. |
| Q37477191 | Shigella Vaccine Development: Finding the Path of Least Resistance |
| Q53695492 | Shigella infection in children under 5 years old in western French Guiana. |
| Q35221181 | Shigella outer membrane protein PSSP-1 is broadly protective against Shigella infection |
| Q37689835 | Shigella sonnei Bacteremia Presenting with Profound Hepatic Dysfunction. |
| Q92058286 | Shigella sonnei O-Antigen Inhibits Internalization, Vacuole Escape, and Inflammasome Activation |
| Q56383780 | Shigellosis |
| Q26739692 | Shigellosis: Epidemiology in India |
| Q35909689 | Species-wide whole genome sequencing reveals historical global spread and recent local persistence in Shigella flexneri |
| Q47093813 | Stable Chromosomal Expression of Shigella flexneri 2a and 3a O-Antigens in the Live Salmonella Oral Vaccine Vector Ty21a. |
| Q40087889 | Stable expression of Shigella dysenteriae serotype 1 O-antigen genes integrated into the chromosome of live Salmonella oral vaccine vector Ty21a |
| Q34518265 | Status of vaccine research and development for Shigella |
| Q36164678 | Stx-Producing Shigella Species From Patients in Haiti: An Emerging Pathogen With the Potential for Global Spread |
| Q38648228 | Summary of workshop "global burden of diarrheal diseases among children in developing countries: Incidence, etiology, and insights from new molecular diagnostic techniques". |
| Q93109786 | The Autotransporter IcsA Promotes Shigella flexneri Biofilm Formation in the Presence of Bile Salts |
| Q37314114 | The First Report of a Fully Sequenced Resistance Plasmid from Shigella boydii |
| Q26825840 | The Rising Dominance of Shigella sonnei: An Intercontinental Shift in the Etiology of Bacillary Dysentery |
| Q30597282 | The extant World War 1 dysentery bacillus NCTC1: a genomic analysis |
| Q38753453 | The genomic signatures of Shigella evolution, adaptation and geographical spread |
| Q39362868 | The synthesis of OspD3 (ShET2) in Shigella flexneri is independent of OspC1. |
| Q28597463 | Travel- and Community-Based Transmission of Multidrug-Resistant Shigella sonnei Lineage among International Orthodox Jewish Communities |
| Q57946228 | Two novel mutations in among isolated from Jiangsu Province of China, 2016 |
| Q38991332 | Update on: Shigella new serogroups/serotypes and their antimicrobial resistance |
| Q30275836 | Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study |
| Q40098097 | Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice |
| Q35706366 | Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru) |
| Q47722353 | WHO consultation on ETEC and Shigella burden of disease, Geneva, 6-7th April 2017: Meeting report |
Search more.